共 50 条
Efficacy and safety of intra-articular botulinum toxin injection therapy for joint pain: A systematic review and meta-analysis
被引:0
|作者:
Gagnie, Mathieu
[1
]
Daste, Camille
[1
,2
]
Campagna, Raphael
[3
]
Drape, Jean-Luc
[2
,3
,4
]
Feydy, Antoine
[2
,3
,4
]
Guerini, Henri
[3
]
Lefevre-Colau, Marie-Martine
[1
,2
,4
,5
]
Rannou, Francoiscois
[1
,2
,6
]
Nguyen, Christelle
[1
,2
,6
]
机构:
[1] Univ Paris Cite, Hop Cochin, AP HP Ctr, Serv Reeduc & Readaptat Appareil Locomoteur & Path, 27 Rue Faubourg St Jacques, F-75014 Paris, France
[2] Univ Paris Cite, Fac Sante, UFR Med, 15 Rue Ecole Med, F-75006 Paris, France
[3] Univ Paris Cite, Hop Cochin, AP HP Ctr, Serv Radiol B, 27 Rue Faubourg St Jacques, F-75014 Paris, France
[4] Hop Cochin, Ctr Rech Epidemiol & Stat, ECaMO Team, INSERM UMR S 1153, S 1153,27 Rue Faubourg St Jacques, F-75014 Paris, France
[5] Federat Rech Handicap & Auton, mie, 8 Rue Croix Jarry, F-75013 Paris, France
[6] INSERM, UMR S 1124, Tox Environm Cibles Therapeut Signalisat Cellulair, Campus St Germain des Pres,45 Rue St-Peres, F-75006 Paris, France
关键词:
Osteoarthritis;
Joint pain;
Musculoskeletal diseases;
Intra-articular injection;
Randomized controlled trial;
Botulinum toxin A;
KNEE OSTEOARTHRITIS;
STANDING-COMMITTEE;
TASK-FORCE;
VOLUME;
RECOMMENDATIONS;
NEUROTOXIN;
MANAGEMENT;
TRIALS;
D O I:
10.1016/j.rehab.2024.101877
中图分类号:
R49 [康复医学];
学科分类号:
100215 ;
摘要:
Background: Studies conducted in various animal models of joint pain showed an anti-nociceptive effect of intra-articular botulinum toxin type A (BoNT-A). Randomized controlled trials (RCTs) in humans suggest a potential effect but results are disparate. Objectives: To assess the efficacy and safety of intra-articular BoNT-A for the treatment of joint pain. Methods: We conducted a systematic review of RCTs comparing the effects of intra-articular BoNT-A to other interventions on pain and activity limitations in the short (<3 months), intermediate (3-6 months) and long term (> 6 months), and their adverse effects, in people with joint pain. We performed a meta-analysis when appropriate. MEDLINE, EMBASE, ClinicalTrials.gov, CINHAL and ICTRP databases were searched from inception to July 9, 2023. Two independent reviewers selected eligible studies and extracted data in a standardized manner. The results of quantitative synthesis were expressed as the standardized mean difference (SMD) (95 % confidence interval). Results: We included 14 RCTs: 437 participants received an intra-articular injection of BoNT-A and 551 received another intervention. Overall, 7 RCTs (549 participants) compared intra-articular BoNT-A with an intra-articular treatment in the knee: short-, intermediate-, and long-term SMD were-0.35 (-0.82 to 0.12),-0.27 (-0.61 to 0.08), and-0.43 (-1.12 to 0.26) for pain and-0.44 (-0.96 to 0.07),-0.24 (-0.63 to 0.15) and-0.42 (-1.26 to 0.42) for activity limitations, respectively. Two RCTs (68 participants) in the shoulder and 1 RCT (60 participants) in the base-of-thumb showed reduced pain in the short term. Minor adverse events were not rare, but no serious adverse events related to intra-articular BoNT-A were reported. Conclusions: Intra-articular BoNT-A may reduce joint pain in the short term for small and medium-sized joints (ie, base-of-thumb and shoulder), but not for large joints (ie, knee).
引用
收藏
页数:10
相关论文